| |||||||||
Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Mating System Heterozygote x +/+ sibling (Female x Male) Species laboratory mouse Generation N10+N1F1N1F7 (13-OCT-08) Donating Investigator Morris Birnbaum, Un of Pennsylvania Schl of Medicine Description
Mice that are homozygous for the targeted mutation are viable and do not display any gross behavioral abnormalities. Homozygotes exhibit lower fertility. Female homozygotes do not nurse well; up to 50% perinatal mortality can occur. No gene product (mRNA or protein) is detected by Northern or Western blot analysis of mouse embryonic fibroblasts. Homozygotes are only 80% of wildtype body weight at birth, and remain small. This mutant mouse strain may be useful in related to organismal growth.Development
A targeting vector containing neomycin resistance and herpes simplex virus thymidine kinase genes was used to disrupt exons 4 through 7 and the 5' end of exon 8. The construct was electroporated into 129P2Ola/Hsd derived E14 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts. The resulting chimeric male animals were crossed to C57BL/6 mice, and then backcrossed to the same for 10 generations (March 2003).
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Congenic Nomenclature
Genetic Quality Control Annual Report
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Akt1tm1Mbb/Akt1tm1Mbb
involves: 129P2/OlaHsd * C57BL/6
- lethality-postnatal
- postnatal lethality (MGI Ref ID J:72176)
- normal numbers of homozygous embryos at E13.5
- by 2-3 weeks after birth, fewer than expected numbers of homozygotes seen
- significant numbers of deaths among homozygotes observed with first three days of life
- survivors were fertile
- growth/size phenotype
- decreased body weight (MGI Ref ID J:72176)
- 20% reduction in body weight at birth
- at 14 months, homozygous males were only about 75% normal weight
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Akt1tm1Mbb related
Cell Biology Research
Genes Regulating Growth and Proliferation
Developmental Biology Research
Growth Defects Growth Defects (homozygous)
| Allele Symbol | Akt1tm1Mbb | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Morris Birnbaum | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | Akt-; | ||
| Mutation Made By | Morris Birnbaum, Un of Pennsylvania Schl of Medicine | ||
| Strain of Origin | 129P2/OlaHsd | ||
| ES Cell Line Name | E14 | ||
| ES Cell Line Strain | 129P2/OlaHsd | ||
| Gene Symbol and Name | Akt1, thymoma viral proto-oncogene 1 | ||
| Chromosome | 12 | ||
| Gene Common Name(s) | AKT; MGC99656; PKB; PKB-ALPHA; PKB/Akt; PKBalpha; PRKBA; RAC; RAC-ALPHA; | ||
| Molecular Note | A neomycin resistance gene was used to replace exons 4 through 7 and the 5' portion of exon 8. Exon 5 is known to encode an lysine residue essential for catalytic activity. Expression was undetected in homozygous mutant animals by both Northern and Western blot analyses. The authors noted that the expression of Akt2 and Akt3 was normal in mice homozygous for the targeted allele. [MGI Ref ID J:72176] | ||
Genotyping Protocols
Akt1tm1Mbb, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Cho H; Thorvaldsen JL; Chu Q; Feng F; Birnbaum MJ. 2001. Akt1/pkbalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276(42):38349-52. [PubMed: 11533044] [MGI Ref ID J:72176]
Akt1tm1Mbb relatedAckah E; Yu J; Zoellner S; Iwakiri Y; Skurk C; Shibata R; Ouchi N; Easton RM; Galasso G; Birnbaum MJ; Walsh K; Sessa WC. 2005. Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest 115(8):2119-2127. [PubMed: 16075056] [MGI Ref ID J:100143]
Boxer RB; Stairs DB; Dugan KD; Notarfrancesco KL; Portocarrero CP; Keister BA; Belka GK; Cho H; Rathmell JC; Thompson CB; Birnbaum MJ; Chodosh LA. 2006. Isoform-specific requirement for Akt1 in the developmental regulation of cellular metabolism during lactation. Cell Metab 4(6):475-90. [PubMed: 17141631] [MGI Ref ID J:129773]
DeBosch B; Sambandam N; Weinheimer C; Courtois M; Muslin AJ. 2006. Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 281(43):32841-51. [PubMed: 16950770] [MGI Ref ID J:117383]
DeBosch B; Treskov I; Lupu TS; Weinheimer C; Kovacs A; Courtois M; Muslin AJ. 2006. Akt1 is required for physiological cardiac growth. Circulation 113(17):2097-104. [PubMed: 16636172] [MGI Ref ID J:122451]
Dickey CA; Koren J; Zhang YJ; Xu YF; Jinwal UK; Birnbaum MJ; Monks B; Sun M; Cheng JQ; Patterson C; Bailey RM; Dunmore J; Soresh S; Leon C; Morgan D; Petrucelli L. 2008. Akt and CHIP coregulate tau degradation through coordinated interactions. Proc Natl Acad Sci U S A 105(9):3622-7. [PubMed: 18292230] [MGI Ref ID J:132677]
Easton RM; Cho H; Roovers K; Shineman DW; Mizrahi M; Forman MS; Lee VM; Szabolcs M; de Jong R; Oltersdorf T; Ludwig T; Efstratiadis A; Birnbaum MJ. 2005. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 25(5):1869-78. [PubMed: 15713641] [MGI Ref ID J:96823]
Fernandez-Hernando C; Ackah E; Yu J; Suarez Y; Murata T; Iwakiri Y; Prendergast J; Miao RQ; Birnbaum MJ; Sessa WC. 2007. Loss of akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab 6(6):446-57. [PubMed: 18054314] [MGI Ref ID J:130443]
Hammerman PS; Fox CJ; Birnbaum MJ; Thompson CB. 2005. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 105(11):4477-83. [PubMed: 15705789] [MGI Ref ID J:98472]
Jacobs SR; Herman CE; Maciver NJ; Wofford JA; Wieman HL; Hammen JJ; Rathmell JC. 2008. Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways. J Immunol 180(7):4476-86. [PubMed: 18354169] [MGI Ref ID J:132993]
Kiessling S; Lutz-Nicoladoni C; Olsson A; Niederegger H; Baier G; Villunger A. 2007. Compensatory mechanisms regulate the Bcl-2 rheostat and lymphocyte survival in the absence of AKT1/PKBalpha. Cell Death Differ 14(1):186-9. [PubMed: 16778831] [MGI Ref ID J:132346]
Lai WS; Xu B; Westphal KG; Paterlini M; Olivier B; Pavlidis P; Karayiorgou M; Gogos JA. 2006. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc Natl Acad Sci U S A 103(45):16906-11. [PubMed: 17077150] [MGI Ref ID J:117100]
Li D; August S; Woulfe DS. 2008. GSK3beta is a negative regulator of platelet function and thrombosis. Blood 111(7):3522-30. [PubMed: 18218855] [MGI Ref ID J:133503]
Li G; Anderson RE; Tomita H; Adler R; Liu X; Zack DJ; Rajala RV. 2007. Nonredundant role of Akt2 for neuroprotection of rod photoreceptor cells from light-induced cell death. J Neurosci 27(1):203-11. [PubMed: 17202487] [MGI Ref ID J:117208]
Mogi M; Yang J; Lambert JF; Colvin GA; Shiojima I; Skurk C; Summer R; Fine A; Quesenberry PJ; Walsh K. 2003. Akt signaling regulates side population cell phenotype via Bcrp1 translocation. J Biol Chem 278(40):39068-75. [PubMed: 12851395] [MGI Ref ID J:132379]
Phung TL; Ziv K; Dabydeen D; Eyiah-Mensah G; Riveros M; Perruzzi C; Sun J; Monahan-Earley RA; Shiojima I; Nagy JA; Lin MI; Walsh K; Dvorak AM; Briscoe DM; Neeman M; Sessa WC; Dvorak HF; Benjamin LE. 2006. Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell 10(2):159-70. [PubMed: 16904613] [MGI Ref ID J:112695]
Rasoulpour T; DiPalma K; Kolvek B; Hixon M. 2006. Akt1 suppresses radiation-induced germ cell apoptosis in vivo. Endocrinology 147(9):4213-21. [PubMed: 16763066] [MGI Ref ID J:129523]
Wofford JA; Wieman HL; Jacobs SR; Zhao Y; Rathmell JC. 2008. IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood 111(4):2101-11. [PubMed: 18042802] [MGI Ref ID J:131334]
Woulfe D; Jiang H; Morgans A; Monks R; Birnbaum M; Brass LF. 2004. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 113(3):441-50. [PubMed: 14755341] [MGI Ref ID J:87588]
Xin X; Chen S; Khan ZA; Chakrabarti S. 2007. Akt activation and augmented fibronectin production in hyperhexosemia. Am J Physiol Endocrinol Metab 293(4):E1036-44. [PubMed: 17666488] [MGI Ref ID J:125528]
Animal Health Reports
Room Number AX12
Colony Maintenance
Breeding & Husbandry This strain originated on a B6;129 background and has been backcrossed to C57BL/6 for at least 10 generations (March 2003). The strain is maintained as a heterozygote. Homozygotes are reported to be less fertile. Female homozygotes do not nurse well; up to 50% perinatal mortality can occur. Mating System Heterozygote x +/+ sibling (Female x Male) Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Weeks of Age Price* Gender Genotypes Provided Individual Mouse Price $236.40 Female or Male Heterozygous for Akt1tm1Mbb *Price(s) in US dollars ($)
Pairs /Price* Pair Genotype $288.65 Heterozygous for Akt1tm1Mbb x Wild-type for Akt1tm1Mbb $288.65 Wild-type for Akt1tm1Mbb x Heterozygous for Akt1tm1Mbb
| Supply Notes |
|
|---|
| Pricing for International shipping destinations |
|
Weeks of Age Price* Gender Genotypes Provided Individual Mouse Price $307.40 Female or Male Heterozygous for Akt1tm1Mbb *Price(s) in US dollars ($)
Pairs /Price* Pair Genotype $375.30 Heterozygous for Akt1tm1Mbb x Wild-type for Akt1tm1Mbb $375.30 Wild-type for Akt1tm1Mbb x Heterozygous for Akt1tm1Mbb
| Supply Notes |
|
|---|
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of ~nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within 48 hours of order placement. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.